InspireMD shareholders approve 66.7% increase in authorized shares to 250M

Filed June 3, 2026 · Period ending June 3, 2026 · ~1 min read

Key Changes

• high

  Shareholders approved expanding authorized common stock from 150M to 250M shares (66.7% increase) with 91.3% support, providing capacity for future equity raises but increasing dilution risk. Proposal passed with 31.6M votes for vs 3.0M against, representing 67.3% of 46.9M shares outstanding.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
• medium

  Three Class 3 directors re-elected for three-year terms. Marvin Slosman received 93.6% support (25.1M for, 1.7M withheld), while Raymond Cohen and Dan Dearen each received ~85% support (22.7M and 22.8M for, 4.1M and 4.1M withheld). 7.8M broker non-votes on each.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
• low

  Shareholders ratified Kesselman & Kesselman (PwC member firm) as 2026 auditor with 99.2% support (34.4M for vs 244K against), representing 73.3% of shares outstanding.

  Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →